We link your study start-up to clinical execution
Positive long-term follow-up data from type 1 diabetes vaccine candidate/pentavalent human CVB vaccine candidate
Regulatory Affairs – Local Presence and Expertise
Drug Development & Clinical Trial Unit – We link your science to clinic
We always work backwards
OncoZenge Receives European Regulatory Approval to Start Pivotal Phase III Trial of BupiZenge™
IMPD as a Strategic CMC Asset — Not Just a Regulatory Requirement
LINK Medical supports Isofol following regulatory approval of optimized Phase Ib/II study design
Ribo Submits Phase 2b Clinical Trial Application for world’s first siRNA FXI inhibitor in atrial fibrillation
Strengthening the link from CMC to clinic
Contact us and we will tell you more
Search the site
Search on LINK Medical